psoriasis

Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial
BioSpace
Wed, 09/18/19 - 06:59 pm
Sienna Biopharmaceuticals
bankruptcy
psoriasis
SNA-120
Skyrizi looks ready to soar after strong launch
Biopharma Dive
Wed, 09/4/19 - 11:23 pm
AbbVie
Skyrizi
psoriasis
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
Eli Lilly's Taltz bests J&J rival Tremfya in head-to-head psoriasis tilt
Fierce Pharma
Tue, 08/13/19 - 11:40 am
Eli Lilly
Taltz
JNJ
Tremfya
psoriasis
AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib
Fierce Pharma
Fri, 07/26/19 - 12:07 pm
AbbVie
Humira
biosimilars
Europe
psoriasis
rheumatoid arthritis
Skyrizi
Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales
Fierce Pharma
Tue, 06/11/19 - 06:00 pm
Eli Lilly
Taltz
psoriasis
Ramaswamy's Dermavant Updates $124 Million IPO Filing
CP Wire
Mon, 06/10/19 - 09:53 am
Dermavant
IPOs
tapinarof
psoriasis
dermatitis
Vivek Ramaswamy
Ramaswamy's Dermavant Updates $124 Million IPO Filing
Mon, 06/10/19 - 09:46 am
Dermavant
tapinarof
psoriasis
dermatitis
IPOs
AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst
Fierce Pharma
Mon, 05/20/19 - 11:07 pm
AbbVie
Humira
Skyrizi
drug launches
psoriasis
drug pricing
formulary
AbbVie successor to Humira in psoriasis gains FDA approval
BioCentury
Tue, 04/23/19 - 10:59 pm
AbbVie
Humira
psoriasis
Skyrizi
FDA
AbbVie gets its first approval for a drug execs believe could be worth up to $5B in annual sales
Endpoints
Wed, 03/27/19 - 10:19 am
AbbVie
Japan
psoriasis
risankizumab
Skyrizi
AbbVie's immunology blockbuster-to-be Skyrizi picks up first global approval
Fierce Pharma
Tue, 03/26/19 - 11:04 pm
AbbVie
Japan
Skyrizi
psoriasis
psoriatic arthritis
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China
Pharmaceutical Business Review
Tue, 03/5/19 - 10:00 am
Novartis
Cosentyx
China
psoriasis
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
RAPS.org
Mon, 03/4/19 - 12:08 pm
Novartis
Janssen
JNJ
psoriasis
false advertising
Tremfya
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
Fri, 03/1/19 - 11:56 am
JNJ
Janssen
Tremfya
psoriasis
Novartis
Cosentyx
Eli Lilly
Taltz
FDA approves J&J’s Tremfya self-injection pen for psoriasis
Drug Delivery Business News
Wed, 01/30/19 - 06:52 pm
JNJ
FDA
Tremfya
psoriasis
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
Fierce Pharma
Wed, 01/9/19 - 12:56 pm
JNJ
JPMHC 2019
immunology
psoriasis
Tremfya
Microbiome Report for Week Ending 12/1/18
CP Wire
Sat, 12/8/18 - 02:42 pm
microbiome
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD

Pages